Valuation: Nexentis Technologies Inc.

Market Cap 895K 802K 740K 669K 1.25M 85.25M 1.27M 8.83M 3.52M 44.62M 3.36M 3.29M 141M P/E 2024
-0.28x
P/E 2025 -0.34x
Enterprise Value -2.18M -1.96M -1.8M -1.63M -3.05M -208M -3.1M -21.53M -8.59M -109M -8.2M -8.02M -345M EV / Sales 2024
1.64x
EV / Sales 2025 -
Free-Float
87.05%
Yield 2024 *
-
Yield 2025 -
1 day+0.40%
1 week+11.29%
Current month-54.60%
1 month-54.93%
3 months-57.36%
6 months-86.57%
Current year-94.63%
1 week 0.51
Extreme 0.5115
0.79
1 month 0.5
Extreme 0.5046
1.5
Current year 0.5
Extreme 0.5046
23.8
1 year 0.5
Extreme 0.5046
24.22
3 years 0.5
Extreme 0.5046
1,849.73
5 years 0.5
Extreme 0.5046
15,006.28
10 years 0.5
Extreme 0.5046
54,022.91
Manager TitleAgeSince
Chief Executive Officer 60 05/11/2020
Director of Finance/CFO 39 18/04/2022
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 54 26/08/2020
Chairman 62 24/05/2021
Director/Board Member 54 26/08/2020
Date Insider Type Main position Quantity % Market Cap. Importance
2/9/26 A Free

Chief Financial Officer

50,000 1.8639%
2/9/26 A Free

Chairman

116,286 4.3350%
2/9/26 A Free

Chief Executive Officer

100,000 3.7279%
Change 5-day change 1-year change 3-year change Capi.($)
+0.40%+11.29%-97.39%-99.87% 913K
-0.80%+0.10%+20.52%+24.42% 32.82B
-1.53%-0.40%+40.33%+47.83% 18.15B
-1.95%-3.82%-8.57%+29.68% 17.54B
-0.52%+1.77%-7.56%-11.13% 14.66B
+0.11%-.--%-.--%-.--% 12.96B
-0.46%-2.31%+5.85%+9.33% 10.85B
0.00%-7.97%-1.29%+150.94% 9.45B
-0.22%-.--%-.--%-.--% 8.3B
+1.24%-10.81% - - 7.56B
Average -0.37%+0.77%-5.34%+16.80% 13.23B
Weighted average by Cap. -0.69%-0.13%+9.58%+28.50%

Financials

2024 2025
Net sales 210K 188K 174K 157K 294K 20M 298K 2.07M 826K 10.47M 788K 771K 33.15M -
Net income -5.19M -4.65M -4.29M -3.88M -7.26M -495M -7.38M -51.2M -20.42M -259M -19.49M -19.07M -820M -4M -3.59M -3.31M -2.99M -5.6M -381M -5.69M -39.47M -15.75M -200M -15.03M -14.71M -632M
Net Debt -2.48M -2.23M -2.05M -1.86M -3.47M -237M -3.53M -24.5M -9.77M -124M -9.33M -9.13M -392M -3.08M -2.76M -2.54M -2.3M -4.31M -293M -4.37M -30.35M -12.11M -153M -11.56M -11.31M -486M
Projected Income Statement - Annual - Nexentis Technologies Inc.
Logo Nexentis Technologies Inc.
Nexentis Technologies Inc, formerly known as N2OFF, Inc., is an AI and data-driven computational biotech platform focused on mitochondrial biology, precision oncology and inflammatory metabolic diseases. Through its subsidiary MitoCareX Bio Ltd. The company uses a proprietary discovery engine targeting the mitochondrial SLC25 carrier family using its MITOLINE algorithm and structure guided virtual screening workflows. MITOLINE, its proprietary computational platform, is designed to allow proper homology modeling of mitochondrial membrane proteins, particularly transport proteins. It enables three-dimensional structural modeling and large-scale virtual screening, MITOLINE opens access to a novel untapped target space, allowing the Company to identify small-molecule modulators that directly disrupt cancer metabolism with the potential of minimizing systemic toxicity.
Employees
8
Date Price Change Volume
29/10/26 $0.6310 +0.40% 1,707,300
28/10/26 $0.6285 +8.36% 700,503
27/10/26 $0.5800 +3.15% 146,153
26/10/26 $0.5623 +7.27% 543,960
23/10/26 $0.5242 -7.55% 30,816
  1. Stock Market
  2. Stocks
  3. NXTS Stock